EGFR-activated myofibroblasts promote metastasis of pancreatic cancer

Gianluca Mucciolo,Joaquín Araos Henríquez,Muntadher Jihad,Sara Pinto Teles,Judhell S Manansala,Wenlong Li,Sally Ashworth,Eloise G Lloyd,Priscilla S W Cheng,Weike Luo,Akanksha Anand,Ashley Sawle,Anna Piskorz,Giulia Biffi,Judhell S. Manansala,Eloise G. Lloyd,Priscilla S.W. Cheng
DOI: https://doi.org/10.1016/j.ccell.2023.12.002
IF: 50.3
2024-01-09
Cancer Cell
Abstract:Mucciolo et al. demonstrate EGFR/ERBB2 signaling activation in myofibroblastic cancer-associated fibroblasts (myCAFs) in pancreatic ductal adenocarcinoma (PDAC). EGFR-activated myCAFs promote metastasis in PDAC mouse models, revealing a previously unappreciated functional complexity of myCAFs. This knowledge could be used to design therapies that target PDAC malignant cells and tumor-promoting fibroblast populations.
oncology,cell biology
What problem does this paper attempt to address?